Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics.
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 27 Nov 2015 New trial record